Top in endocrinology: Continuous glucose monitoring; genetic testing for hypothyroidism
Click Here to Manage Email Alerts
It remains unclear whether continuous glucose monitoring benefits people without diabetes, researchers reported.
In a recent study, they found a discordance between glucose management indicator (GMI), a metric of continuous glucose monitoring that estimates HbA1c, and laboratory-measured HbA1c.
“Based on the findings from our study, it would not be appropriate to use GMI as a substitute for HbA1c in people without diabetes,” Viral N. Shah, MD, an associate professor of medicine and pediatrics in the adult clinic of the Barbara Davis Center for Diabetes at the University of Colorado Anschutz Medical Campus, told Healio.
It was the top story in endocrinology last week.
The second top story covered a study on the potential of using genetic testing to assist in the diagnosis of congenital hypothyroidism in children. Researchers reported that genetic testing led to a change in diagnosis for 10 of 48 children with congenital hypothyroidism.
Read these and more top stories in endocrinology below:
Q&A: CGM metrics may not provide accurate health data for people without diabetes
Continuous glucose monitoring has been firmly established as beneficial for helping people with diabetes understand their glucose profile, but whether these metrics translate for people without diabetes is still unclear. Read more.
Genetic testing may help confirm diagnosis for children with congenital hypothyroidism
Genetic testing can be used to confirm a congenital hypothyroidism diagnosis for children, according to findings published in the European Thyroid Journal. Read more.
Standalone reader for FreeStyle Libre 3 CGM receives FDA clearance
The FDA granted clearance for use of a standalone reader to display real-time glucose levels with an integrated continuous glucose monitoring system, according to a press release. Read more.
Plant-based low-carb diet linked to lower mortality risk in type 2 diabetes
Low-carbohydrate diets centered on macronutrients from whole grains, fruit and vegetables are associated with a lower mortality risk for people with type 2 diabetes, according to study data. Read more.
Intensive diabetes management does not preserve C-peptide in youths with type 1 diabetes
Older children with newly diagnosed type 1 diabetes who received intensive diabetes management with automated insulin delivery had no difference in pancreatic C-peptide levels compared with standard care, according to study data. Read more.